AbInitio Bio
Last verified 2026-09-25. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.0Mattributed |
|---|---|
| Latest round | seed, $1.0M, 2026-04-01attributed |
| Founded | 2024 |
| Headquarters | Cambridge, United Kingdom |
| Industry | healthtech |
| Stage | seed |
| Website | abinitio-bio.com |
AbInitio Bio builds foundation models that streamline biologic drug manufacturing, covering manufacturability assessment, process development, and characterization. It serves pharma and biotech teams looking to speed pipelines from candidate selection through commercial scale-up. It scores molecules upfront and suggests changes that lower aggregation before lab work begins.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-04-01 | seed | $1.0M | yc |
Detected tech stack
Cloudflare, Three.js, Angular Material, cdnjs, AngularJS, render
Provenance
| Fact | Status | Basis |
|---|---|---|
| Seed, $1.0M | attributed | yc named as publisher. No document URL on file. |
| Total raised $1.0M | attributed | yc named as publisher. No document URL on file. |
| Company existence | sourced | Y Combinator named as publisher. Document, retrieved 2026-09-17. |
| Description | self-reported | abinitio-bio.com, read 2026-09-25 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-24Existence: self-reported → sourced, Y Combinator, document, retrieved 2026-09-17 | Existence | self-reported → sourced | Y Combinator, document, retrieved 2026-09-17 |
Records begin 2026-09-24. All changes